Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
NeoTX Therapeutics Ltd.
NeoTX Therapeutics Ltd.
Maastricht University Medical Center
Gustave Roussy, Cancer Campus, Grand Paris
AstraZeneca
MultiVir, Inc.